{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:09:57Z","timestamp":1781276997306,"version":"3.54.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,5]]},"DOI":"10.7759\/cureus.61713","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T10:30:48Z","timestamp":1717583448000},"source":"Crossref","is-referenced-by-count":6,"title":["Clinical and Laboratory Diagnosis of Antiphospholipid Syndrome: A Review"],"prefix":"10.7759","author":[{"given":"Muhamad Aidil","family":"Zahidin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salfarina","family":"Iberahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Nazri","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zefarina","family":"Zulkafli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor Haslina","family":"Mohd Noor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-016-0430-5","article-title":"The antiphospholipid syndrome: from pathophysiology to treatment","volume":"17","author":"Negrini S","year":"2017","unstructured":"Negrini S, Pappalardo F, Murdaca G, Indiveri F, Puppo F. The antiphospholipid syndrome: from pathophysiology to treatment. Clin Exp Med. 2017, 17:257-67. 10.1007\/s10238-016-0430-5","journal-title":"Clin Exp Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2005.1.462","article-title":"Thrombosis and the antiphospholipid syndrome","author":"Ortel TL","year":"2005","unstructured":"Ortel TL. Thrombosis and the antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program. 2005, 462-8. 10.1182\/asheducation-2005.1.462","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.108.182204","article-title":"Venous thrombosis in the antiphospholipid syndrome","volume":"29","author":"Farmer-Boatwright MK","year":"2009","unstructured":"Farmer-Boatwright MK, Roubey RA. Venous thrombosis in the antiphospholipid syndrome. Arterioscler Thromb Vasc Biol. 2009, 29:321-5. 10.1161\/ATVBAHA.108.182204","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2016.1.707","article-title":"Prevention of thrombosis in antiphospholipid syndrome","volume":"2016","author":"Lim W","year":"2016","unstructured":"Lim W. Prevention of thrombosis in antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program. 2016, 2016:707-13. 10.1182\/asheducation-2016.1.707","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-021-01038-2","article-title":"Epidemiology of antiphospholipid syndrome in the general population","volume":"23","author":"Dabit JY","year":"2022","unstructured":"Dabit JY, Valenzuela-Almada MO, Vallejo-Ramos S, Duarte-Garc\u00eda A. Epidemiology of antiphospholipid syndrome in the general population. Curr Rheumatol Rep. 2022, 23:85. 10.1007\/s11926-021-01038-2","journal-title":"Curr Rheumatol Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12959-022-00409-8","article-title":"The trends in the incidence and thrombosis-related comorbidities of antiphospholipid syndrome: a 14-year nationwide population-based study","volume":"20","author":"Yao WC","year":"2022","unstructured":"Yao WC, Leong KH, Chiu LT, et al.. The trends in the incidence and thrombosis-related comorbidities of antiphospholipid syndrome: a 14-year nationwide population-based study. Thromb J. 2022, 20:50. 10.1186\/s12959-022-00409-8","journal-title":"Thromb J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2019-lsm.189","article-title":"189 epidemiology of antiphospholipid syndrome: a population-based study","volume":"6","author":"Duarte-Garcia A","year":"2019","unstructured":"Duarte-Garcia A, Pham M, Crowson C, et al.. 189 epidemiology of antiphospholipid syndrome: a population-based study. Lupus Science and Medicine. 2019, 6:143. 10.1136\/lupus-2019-lsm.189","journal-title":"Lupus Science and Medicine"},{"key":"ref8","article-title":"Antiphospholipid syndrome","author":"Erkan D","year":"2013","unstructured":"Erkan D, Lockshin MD. Antiphospholipid syndrome. Clinical Immunology E-Book, 5th Edition. Rich RR, Fleisher TA, Shearer WT, Schroeder HW, Frew AJ, Weyand C (ed): Elsevier, 2013. 740-6."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1705454","article-title":"Diagnosis and management of the antiphospholipid syndrome","volume":"378","author":"Garcia D","year":"2018","unstructured":"Garcia D, Erkan D. Diagnosis and management of the antiphospholipid syndrome. N Engl J Med. 2018, 378:2010-21. 10.1056\/NEJMra1705454","journal-title":"N Engl J Med"},{"key":"ref10","article-title":"Antiphospholipid syndrome","author":"Bustamante JG","year":"2023","unstructured":"Bustamante JG, Goyal A, Singhal M. Antiphospholipid syndrome. StatPearls Publishing, 2023."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis S","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, et al.. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006, 4:295-306. 10.1111\/j.1538-7836.2006.01753.x","journal-title":"J Thromb Haemost"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera R","year":"2002","unstructured":"Cervera R, Piette JC, Font J, et al.. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002, 46:1019-27. 10.1002\/art.10187","journal-title":"Arthritis Rheum"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2008.11.005","article-title":"A critical assessment of the role of antiphospholipid antibodies in infertility","volume":"80","author":"Buckingham KL","year":"2009","unstructured":"Buckingham KL, Chamley LW. A critical assessment of the role of antiphospholipid antibodies in infertility. J Reprod Immunol. 2009, 80:132-45. 10.1016\/j.jri.2008.11.005","journal-title":"J Reprod Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2011.04348.x","article-title":"Migraineurs show a high prevalence of antiphospholipid antibodies","volume":"9","author":"Cavestro C","year":"2011","unstructured":"Cavestro C, Micca G, Molinari F, et al.. Migraineurs show a high prevalence of antiphospholipid antibodies. J Thromb Haemost. 2011, 9:1350-4. 10.1111\/j.1538-7836.2011.04348.x","journal-title":"J Thromb Haemost"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.42.3.681","article-title":"Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus","volume":"42","author":"Montalb\u00e1n J","year":"1992","unstructured":"Montalb\u00e1n J, Cervera R, Font J, et al.. Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus. Neurology. 1992, 42:681-2. 10.1212\/wnl.42.3.681","journal-title":"Neurology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.50.5.1433","article-title":"Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events: a prospective study","volume":"50","author":"Tietjen GE","year":"1998","unstructured":"Tietjen GE, Day M, Norris L, Aurora S, Halvorsen A, Schultz LR, Levine SR. Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events: a prospective study. Neurology. 1998, 50:1433-40. 10.1212\/wnl.50.5.1433","journal-title":"Neurology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/pmj.79.928.81","article-title":"Migraine, memory loss, and \"multiple sclerosis \". Neurological features of the antiphospholipid (Hughes') syndrome","volume":"79","author":"Hughes GR","year":"2003","unstructured":"Hughes GR. Migraine, memory loss, and \"multiple sclerosis \". Neurological features of the antiphospholipid (Hughes') syndrome. Postgrad Med J. 2003, 79:81-3. 10.1136\/pmj.79.928.81","journal-title":"Postgrad Med J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.72.5.647","article-title":"Anticardiolipin antibodies in patients with multiple sclerosis do not represent a subgroup of patients according to clinical, familial, and biological characteristics","volume":"72","author":"Heinzlef O","year":"2002","unstructured":"Heinzlef O, Weill B, Johanet C, Sazdovitch V, Caillat-Zucman S, Tournier-Lasserve E, Roullet E. Anticardiolipin antibodies in patients with multiple sclerosis do not represent a subgroup of patients according to clinical, familial, and biological characteristics. J Neurol Neurosurg Psychiatry. 2002, 72:647-9. 10.1136\/jnnp.72.5.647","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.006163","article-title":"Seronegative antiphospholipid syndrome","volume":"62","author":"Hughes GR","year":"2003","unstructured":"Hughes GR, Khamashta MA. Seronegative antiphospholipid syndrome. Ann Rheum Dis. 2003, 62:1127. 10.1136\/ard.2003.006163","journal-title":"Ann Rheum Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102407","article-title":"Does seronegative obstetric APS exist? \"pro\" and \"cons\"","volume":"18","author":"Conti F","year":"2019","unstructured":"Conti F, Andreoli L, Crisafulli F, Mancuso S, Truglia S, Tektonidou MG. Does seronegative obstetric APS exist? \"pro\" and \"cons\". Autoimmun Rev. 2019, 18:102407. 10.1016\/j.autrev.2019.102407","journal-title":"Autoimmun Rev"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2012.09037.x","article-title":"Guidelines on the investigation and management of antiphospholipid syndrome","volume":"157","author":"Keeling D","year":"2012","unstructured":"Keeling D, Mackie I, Moore GW, Greer IA, Greaves M. Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol. 2012, 157:47-58. 10.1111\/j.1365-2141.2012.09037.x","journal-title":"Br J Haematol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.54.101601.152412","article-title":"The antiphospholipid syndrome","volume":"54","author":"Rand JH","year":"2003","unstructured":"Rand JH. The antiphospholipid syndrome. Annu Rev Med. 2003, 54:409-24. 10.1146\/annurev.med.54.101601.152412","journal-title":"Annu Rev Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra002974","article-title":"The antiphospholipid syndrome","volume":"346","author":"Levine JS","year":"2002","unstructured":"Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med. 2002, 346:752-63. 10.1056\/NEJMra002974","journal-title":"N Engl J Med"},{"key":"ref24","unstructured":"Antiphospholipid syndrome. (2018). Accessed. May 2024: https:\/\/discovery.ucl.ac.uk\/id\/eprint\/10040540\/1\/Giles%20Medicine%20APS%2017072017.pdf."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/art.21437","article-title":"Increased platelet deposition on extracellular matrix under flow conditions in patients with antiphospholipid syndrome who experience thrombotic events","volume":"52","author":"Levy Y","year":"2005","unstructured":"Levy Y, Shenkman B, Tamarin I, et al.. Increased platelet deposition on extracellular matrix under flow conditions in patients with antiphospholipid syndrome who experience thrombotic events. Arthritis Rheum. 2005, 52:4011-7. 10.1002\/art.21437","journal-title":"Arthritis Rheum"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2011.52","article-title":"Pathogenesis of antiphospholipid syndrome: understanding the antibodies","volume":"7","author":"Meroni PL","year":"2011","unstructured":"Meroni PL, Borghi MO, Raschi E, Tedesco F. Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Nat Rev Rheumatol. 2011, 7:330-9. 10.1038\/nrrheum.2011.52","journal-title":"Nat Rev Rheumatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01295.x","article-title":"A prospective study of antibodies to beta2-glycoprotein I and prothrombin, and risk of thrombosis","volume":"3","author":"Forastiero R","year":"2005","unstructured":"Forastiero R, Martinuzzo M, Pombo G, et al.. A prospective study of antibodies to beta2-glycoprotein I and prothrombin, and risk of thrombosis. J Thromb Haemost. 2005, 3:1231-8. 10.1111\/j.1538-7836.2005.01295.x","journal-title":"J Thromb Haemost"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1177\/107602960000600301","article-title":"Recurrent miscarriage syndrome due to blood coagulation protein\/platelet defects: prevalence, treatment and outcome results. DRW Metroplex Recurrent Miscarriage Syndrome Cooperative Group","volume":"6","author":"Bick RL","year":"2000","unstructured":"Bick RL. Recurrent miscarriage syndrome due to blood coagulation protein\/platelet defects: prevalence, treatment and outcome results. DRW Metroplex Recurrent Miscarriage Syndrome Cooperative Group. Clin Appl Thromb Hemost. 2000, 6:115-25. 10.1177\/107602960000600301","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2017.01.026","article-title":"Antiphospholipid antibody profile based obstetric outcomes\u00a0of primary antiphospholipid syndrome: the\u00a0PREGNANTS study","volume":"216","author":"Saccone G","year":"2017","unstructured":"Saccone G, Berghella V, Maruotti GM, et al.. Antiphospholipid antibody profile based obstetric outcomes\u00a0of primary antiphospholipid syndrome: the\u00a0PREGNANTS study. Am J Obstet Gynecol. 2017, 216:525.e1-525.e12. 10.1016\/j.ajog.2017.01.026","journal-title":"Am J Obstet Gynecol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1082265","article-title":"Primary, secondary, and catastrophic antiphospholipid syndrome: what's in a name?","volume":"34","author":"Harris EN","year":"2008","unstructured":"Harris EN, Pierangeli SS. Primary, secondary, and catastrophic antiphospholipid syndrome: what's in a name?. Semin Thromb Hemost. 2008, 34:219-26. 10.1055\/s-0028-1082265","journal-title":"Semin Thromb Hemost"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2012-0578","article-title":"Trials and tribulations in lupus anticoagulant testing","volume":"51","author":"Favaloro EJ","year":"2013","unstructured":"Favaloro EJ. Trials and tribulations in lupus anticoagulant testing. Clin Chem Lab Med. 2013, 51:253-6. 10.1515\/cclm-2012-0578","journal-title":"Clin Chem Lab Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/PAT.0000000000000142","article-title":"Antiphospholipid antibody testing for the antiphospholipid syndrome: a comprehensive practical review including a synopsis of challenges and recent guidelines","volume":"46","author":"Favaloro EJ","year":"2014","unstructured":"Favaloro EJ, Wong RC. Antiphospholipid antibody testing for the antiphospholipid syndrome: a comprehensive practical review including a synopsis of challenges and recent guidelines. Pathology. 2014, 46:481-95. 10.1097\/PAT.0000000000000142","journal-title":"Pathology"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03555.x","article-title":"Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis","volume":"7","author":"Pengo V","year":"2009","unstructured":"Pengo V, Tripodi A, Reber G, Rand JH, Ortel TL, Galli M, De Groot PG. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 2009, 7:1737-40. 10.1111\/j.1538-7836.2009.03555.x","journal-title":"J Thromb Haemost"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-62703-339-8_7","article-title":"Lupus anticoagulant testing","author":"Moffat K","year":"2013","unstructured":"Moffat K, Raby A, Crowther M. Lupus anticoagulant testing. Methods Mol Biol. 2013. 992:97-108. 10.1007\/978-1-62703-339-8_7"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.10.010","article-title":"Thrombotic antiphospholipid syndrome: a practical guide to diagnosis and management","volume":"198","author":"Sayar Z","year":"2021","unstructured":"Sayar Z, Moll R, Isenberg D, Cohen H. Thrombotic antiphospholipid syndrome: a practical guide to diagnosis and management. Thromb Res. 2021, 198:213-21. 10.1016\/j.thromres.2020.10.010","journal-title":"Thromb Res"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2013.1.675","article-title":"Antiphospholipid syndrome","volume":"2013","author":"Lim W","year":"2013","unstructured":"Lim W. Antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program. 2013, 2013:675-80. 10.1182\/asheducation-2013.1.675","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15241","article-title":"Anti-\u03b22-glycoprotein I and anti-prothrombin antibodies cause lupus anticoagulant through different mechanisms of action","volume":"19","author":"Noordermeer T","year":"2021","unstructured":"Noordermeer T, Molhoek JE, Schutgens RE, et al.. Anti-\u03b22-glycoprotein I and anti-prothrombin antibodies cause lupus anticoagulant through different mechanisms of action. J Thromb Haemost. 2021, 19:1018-28. 10.1111\/jth.15241","journal-title":"J Thromb Haemost"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1080\/08916930902882731","article-title":"Identification of rare anti-phospholipid\/protein co-factor autoantibodies in patients with systemic lupus erythematosus","volume":"42","author":"Szodoray P","year":"2009","unstructured":"Szodoray P, Tarr T, Tumpek J, et al.. Identification of rare anti-phospholipid\/protein co-factor autoantibodies in patients with systemic lupus erythematosus. Autoimmunity. 2009, 42:497-506. 10.1080\/08916930902882731","journal-title":"Autoimmunity"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.754469","article-title":"Anti-phosphatidylserine\/prothrombin antibodies at two points: correlation with lupus anticoagulant and thrombotic risk","volume":"12","author":"Egri N","year":"2021","unstructured":"Egri N, Bentow C, Rubio L, et al.. Anti-phosphatidylserine\/prothrombin antibodies at two points: correlation with lupus anticoagulant and thrombotic risk. Front Immunol. 2021, 12:754469. 10.3389\/fimmu.2021.754469","journal-title":"Front Immunol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018026948","article-title":"High risk of adverse pregnancy outcomes in women with a persistent lupus anticoagulant","volume":"3","author":"Gebhart J","year":"2019","unstructured":"Gebhart J, Posch F, Koder S, et al.. High risk of adverse pregnancy outcomes in women with a persistent lupus anticoagulant. Blood Adv. 2019, 3:769-76. 10.1182\/bloodadvances.2018026948","journal-title":"Blood Adv"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/246028-clinical-and-laboratory-diagnosis-of-antiphospholipid-syndrome-a-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T10:30:52Z","timestamp":1717583452000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/246028-clinical-and-laboratory-diagnosis-of-antiphospholipid-syndrome-a-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,5]]},"references-count":40,"URL":"https:\/\/doi.org\/10.7759\/cureus.61713","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,5]]}}}